Author: GlobeNewswire

– Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been…

CANTON, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…

LAS VEGAS, Nov. 21, 2024 (GLOBE NEWSWIRE) — BioAdaptives Inc. (OTC: BDPT) ushered in a new direction by appointing James…

DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of 2024 Annual General Meeting The Board of DXS International plc (“the Company” or…

NEW HAVEN, Conn., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing…

WOODRIDGE, Ill., Nov. 21, 2024 (GLOBE NEWSWIRE) — High Haven Dispensary, recognized as Illinois’ top-rated cannabis retailer, invites cannabis enthusiasts…

RICHMOND, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing…

Conference Call to be held on December 3, 2024WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-…

CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and…

WOBURN, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the…